Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M538Revenue $M42.2Net Margin (%)21.3Z-Score2.4
Enterprise Value $M403EPS $0.8Operating Margin %20.4F-Score6
P/E(ttm))27.8Cash Flow Per Share $0Pre-tax Margin (%)19.0Higher ROA y-yY
Price/Book3.410-y EBITDA Growth Rate %0Quick Ratio3.3Cash flow > EarningsY
Price/Sales6.25-y EBITDA Growth Rate %0Current Ratio3.4Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)11.2Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)15.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M20.3ROI % (ttm)21.6Gross Margin Increase y-yN

Gurus Latest Trades with HPTX

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

HPTX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


HPTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Scharschmidt Bruce FrederickSVP & Chief Medical Officer 2014-07-02Sell200$28-10.18 view
SANDELL SCOTT D10% Owner 2014-06-06Sell1,430$5.54353.97 view
DRANT RYAN D10% Owner 2014-06-06Sell1,134$26.9-6.51 view
BARRETT M JAMES10% Owner 2014-06-06Sell1,430$26.88-6.44 view
BASKETT FOREST10% Owner 2014-06-06Sell1,377$26.9-6.51 view
BARRIS PETER J10% Owner 2014-06-06Sell1,134$26.9-6.51 view
KOLLURI KRISHNA KITTU10% Owner 2014-06-06Sell120$27.19-7.5 view
SOFINNOVA VENTURE PARTNERS VII10% Owner 2014-06-04Sell417,747$27.7-9.21 view
HEALY JAMESDirector 2014-06-04Sell417,747$27.7-9.21 view
Nash Christine ASVP & Chief Commercial Officer 2014-03-06Sell5,100$29.05-13.43 view

Press Releases about HPTX :

Quarterly/Annual Reports about HPTX:

News about HPTX:

Articles On GuruFocus.com


More From Other Websites
Weakness Seen in Avanir Pharmaceuticals (AVNR): Stock Falls 6.5% Sep 19 2014
Tetraphase Pharmaceuticals (TTPH) in Focus: Stocks Up 5.5% Sep 18 2014
Concert Pharmaceuticals (CNCE) Soars: Stock Rises 25.8% Sep 16 2014
PTC Therapeutics (PTCT) Soars: Stock Adds 11.5% is Session Sep 16 2014
Hyperion Therapeutics (HPTX) Upgraded From Hold to Buy Sep 11 2014
Avanir Pharmaceuticals (AVNR) in Focus: Stock Surges 14.4% Sep 11 2014
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Hyperion Therapeutics, Inc.... Sep 10 2014
UPDATE: JMP Securities Reiterates On Hyperion Therapeutics Inc As Diabetes Program Is Discarded Sep 09 2014
Infinity Pharmaceuticals (INFI) Soars: Stock Rises 7.1% Sep 09 2014
Ignyta (RXDX) Jumps: Stock Adds 5.9% in Session Sep 09 2014
Clal Bio Falls as Hyperion Alleges Misconduct at Unit Sep 09 2014
Hyperion reports diabetes drug misconduct Sep 08 2014
Hyperion reports diabetes drug misconduct Sep 08 2014
Evotec profit target in danger after drug trial halted Sep 08 2014
HYPERION THERAPEUTICS INC Files SEC form 8-K, Material Impairments, Other Events, Financial... Sep 08 2014
EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Hyperion... Sep 08 2014
Evotec takes charge for end of diabetes drug development Sep 08 2014
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Hyperion... Sep 08 2014
Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Hyperion... Sep 08 2014
US STOCKS-Futures pointing to modest losses at the open Sep 08 2014

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK